Fundraising Fox

IKJ Capital

Venture capital

Palo Alto · Pre-Seed–Series A

Fox Verdict
Sign up to see your fit

Investment thesis

IKJ Capital backs early-stage healthcare technology companies that take a holistic view of patient care and promote prevention, better access, better care, or better value. Its focus areas include chronic conditions (prediction, prevention, and management), longevity and healthy aging, and mental and brain health. The firm favors a targeted portfolio over a high-volume approach, aiming to support founders closely through advice, its referral network, and scientific and clinical validation of health studies. It operates with a global reach centered on the Americas, with a presence in Palo Alto, New York, and Sao Paulo.

Invests inBiotechDigital HealthHealthtechLongevityMental HealthBrazilLatin AmericaNorth AmericaPalo AltoUnited States

Source: firm website, verified Aug 3, 2026.

Stage
Pre-Seed–Series A
HQ
Palo Alto, US
Leads rounds
Follows
Instruments
Equity
Last 12 months
1 investment
Tracked investments
1

What they invest in

from 1 of 1 portfolio companies

Biotech ×1

HQs:United States×1

Investments · 1 tracked

founders shown can be your intro path
Portal BiotechnologiesMay 2026

BiotechArlington, US

Armon Sharei(Executive Officer, Director)

Portfolio news

latest coverage across their companies

Frequently asked questions

What stage does IKJ Capital invest at?
IKJ Capital invests at the Pre-Seed, Seed, Series A stages.
What sectors does IKJ Capital focus on?
IKJ Capital focuses on Biotech, Digital Health, Healthtech, Longevity, Mental Health.
Where is IKJ Capital located?
IKJ Capital is headquartered in Palo Alto, US.
Does IKJ Capital lead rounds?
IKJ Capital typically participates in rounds rather than leading them.

Similar investors

Featured in lists